COMMUNIQUÉS West-GlobeNewswire

Eyenovia Receives Notices of Allowance from USPTO on Two Additional Patent Applications for Ophthalmic Drug Delivery
05/06/2018
NEW YORK, June 05, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to [...]
TG Therapeutics, Inc. to Present at the Jefferies 2018 Global Healthcare Conference
05/06/2018
Presentation scheduled for Thursday, June 7, 2018 at 10:30am ET NEW YORK, June 05, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that Michael S. Weiss, the Company’s Executive Chairman and [...]
Solon Eiendom ASA : Primary insider notification
05/06/2018
(Oslo, Norway, June 04, 2018) UFI AS has today bought 26 458 shares in Solon Eiendom ASA at a price of NOK 30.20 per share. Solon Eiendom ASA Board Member Øystein A. Landvik owns 33,34 % of the shares in UFI AS. [...]
Results from Oasmia Pharmaceutical’s phase III study have been presented at ASCO annual meeting
05/06/2018
During Monday Oasmia Pharmaceutical AB presented the follow-up results from the completed phase III study with Apealea ® for treatment of ovarian cancer. Uppsala, Sweden, June 5, 2018 - The 2018 ASCO Annual Meeting is [...]
B-Temia to Showcase Keeogo at G7 Summit
05/06/2018
B-Temia / Keeogo invited to G7 Summit Innovation Experience QUÉBEC CITY, June 05, 2018 (GLOBE NEWSWIRE) -- B-Temia Inc., a Canadian biorobotic tech company based in Quebec City and leader in the human mobility market is [...]
B-Temia présente le Keeogo au sommet du G7
05/06/2018
B-Temia / Keeogo est invité à l’Expérience Innovation du Sommet du G7 QUÉBEC, 05 juin 2018 (GLOBE NEWSWIRE) -- B-Temia Inc., une entreprise canadienne de technologie biorobotique basée à Québec et leader sur le marché [...]
Saniona reports positive results from preclinical studies for Tesomet opening op for long-term clinical studies
05/06/2018
PRESS RELEASE June 5, 2018 Saniona, a leading biotech company within ion-channel research, today announced successful completion of the preclinical toxicology studies for Tesomet. The preclinical studies demonstrated [...]
DBV Technologies to Attend Upcoming Investor Conferences
05/06/2018
Montrouge, France, June 5, 2018 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, [...]
DBV Technologies invitée à présenter lors des prochaines Conférences Investisseurs
05/06/2018
Montrouge, France, le 5 juin (7H30 CEST), 2018 DBV Technologies invitée à présenter lors des prochaines Conférences Investisseurs DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : DBVT), société [...]
ESPERITE (ESP) expects publication of Annual Report 2017 before 18 June 2018
05/06/2018
Amsterdam, The Netherlands - 05 June 2018 Esperite regrets to announce that due to the technical issues as reported on 30 April and despite the constant efforts provided by the different teams involved, additional time [...]
Basilea reports presentation of phase 1 clinical data with anticancer drug candidate BAL101553 at ASCO meeting
05/06/2018
Data support expansion into phase 2a Basel, Switzerland, June 05, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that data from the phase 1 dose-escalation parts of two phase 1/2a studies with weekly 48- [...]
Kiadis Pharma announces results of Annual General Meeting
05/06/2018
Kiadis Pharma announces results of Annual General Meeting Amsterdam, The Netherlands, June 5, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS ), a clinical stage [...]
FibroGen to Present at Two Upcoming Investor Conferences
04/06/2018
SAN FRANCISCO, June 04, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN), a biopharmaceutical company, today announced that management will participate in a Fireside Chat at the Jefferies 2018 Healthcare Conference [...]
Kalytera Announces Next Monthly Payment in Shares under Services Agreement with Salzman Group
04/06/2018
SAN FRANCISCO and TEL AVIV, Israel, June 04, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the " Company " or " Kalytera ") today announced that the Company has elected to issue [...]
RadNet, Inc. to Present at the 8th Annual LD Micro Invitational on June 6th
05/06/2018
LOS ANGELES, June 04, 2018 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]
TESARO Summarizes TOPACIO and QUADRA Trial Results Presented at 2018 ASCO Annual Meeting
05/06/2018
TOPACIO data for ZEJULA ® (niraparib) in combination with an anti-PD-1 mAb highlight promising activity in platinum-resistant/refractory ovarian cancer and triple-negative breast cancer beyond patients with BRCA [...]
Public Health Laboratory Leaders Honored by APHL
04/06/2018
Silver Spring, MD, June 04, 2018 (GLOBE NEWSWIRE) -- The Association of Public Health Laboratories (APHL) is pleased to announce the winners of its annual awards for outstanding achievements in laboratory science, [...]
Cannabis Wheaton Announces Results From the Annual and Special Meeting
04/06/2018
VANCOUVER, British Columbia, June 04, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) (" Cannabis Wheaton " or the " Company ") is pleased to announce the results of voting at its annual and special [...]
Optinose Announces Launch of Public Offering of Common Stock
04/06/2018
YARDLEY, Pa., June 04, 2018 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) and commenced a [...]

Pages